Role of the Long Non-coding RNA LINC00052 in Tumors

Overview

Journal Oncol Lett

Specialty Oncology

Date 2021 Mar 11

PMID 33692848

Citations 4

Authors

Dongmei Xiong

Dan Wang

Yanmeng Chen

Affiliations

Soon will be listed here.

Abstract

Long intergenic non-protein coding RNA 52 (LINC00052) is a non-coding RNA with >200 nucleotides in length, which exerts important effects on several physiological and pathological processes of the human body. Recent studies have demonstrated that LINC00052 plays key roles in the tumorigenesis, progression and metastasis of multiple types of human cancer, including hepatocellular carcinoma, breast cancer, colorectal cancer, cervical carcinoma and gastric cancer. However, the associations between LINC00052 and these tumors remain unclear. The present review summarizes the biological functions of LINC00052 during the pathogenic process of certain tumors, and discusses its potential therapeutic targets.

Citing Articles

Accurate Identification of Spatial Domain by Incorporating Global Spatial Proximity and Local Expression Proximity.

Yu Y, He Y, Xie Z Biomolecules. 2024; 14(6).

PMID: 38927077 PMC: 11201407. DOI: 10.3390/biom14060674.

Comparative Transcriptome Profiles of Human HaCaT Cells in Response to Extracts Obtained Using Three Independent Methods by RNA Sequencing.

Cho W, Paek S, Kim S, Jang S, Lee S, Choi H Life (Basel). 2023; 13(2).

PMID: 36836780 PMC: 9961609. DOI: 10.3390/life13020423.

Identification of a novel ceRNA network related to prognosis and immunity in HNSCC based on integrated bioinformatic investigation.

Liu H, Hei G, Zhang L, Jiang Y, Lu H Sci Rep. 2022; 12(1):17560.

PMID: 36266384 PMC: 9584951. DOI: 10.1038/s41598-022-21473-0.

Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma.

Bao L, Wang M, Fan Q J Gastrointest Oncol. 2021; 12(5):2388-2402.

PMID: 34790400 PMC: 8576225. DOI: 10.21037/jgo-21-567.

References

Liu C, Liu L, Chen X, Cheng J, Zhang H, Shen J . Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma. Hepatology. 2016; 64(1):117-29. DOI: 10.1002/hep.28509. View

Zhu L, Yang N, Chen J, Zeng T, Yan S, Liu Y . LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p. Oncotarget. 2017; 8(38):63724-63737. PMC: 5609956. DOI: 10.18632/oncotarget.18892. View

Yan S, Shan X, Chen K, Liu Y, Yu G, Chen Q . LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma. Gene. 2018; 679:138-149. DOI: 10.1016/j.gene.2018.08.038. View

Tian J, Hu X, Gao W, Zhang J, Chen M, Zhang X . Identification of the long non‑coding RNA LET as a novel tumor suppressor in gastric cancer. Mol Med Rep. 2017; 15(4):2229-2234. DOI: 10.3892/mmr.2017.6263. View

Beermann J, Piccoli M, Viereck J, Thum T . Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016; 96(4):1297-325. DOI: 10.1152/physrev.00041.2015. View

Wang Z, Zhang J, Ye M, Zhu M, Zhang B, Roy M . Tumor suppressor role of protein 4.1B/DAL-1. Cell Mol Life Sci. 2014; 71(24):4815-30. PMC: 11113756. DOI: 10.1007/s00018-014-1707-z. View

Choi Y, Song J, Yoon J, Choi W, Nam S, Lee J . Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers. Gastric Cancer. 2013; 17(2):247-54. DOI: 10.1007/s10120-013-0277-3. View

Xiong X, Shi Q, Yang X, Wang W, Tao J . LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. J Cell Physiol. 2019; 234(9):15619-15626. DOI: 10.1002/jcp.28209. View

Wang H, Xu M, Cui X, Liu Y, Zhang Y, Sui Y . Aberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer. Sci Rep. 2016; 6:21755. PMC: 4770418. DOI: 10.1038/srep21755. View

10.

Bian Z, Zhang J, Li M, Feng Y, Wang X, Zhang J . LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clin Cancer Res. 2018; 24(19):4808-4819. DOI: 10.1158/1078-0432.CCR-17-2967. View

11.

Jin W, Kim G, Kim M, Lim M, Yun C, Jeong J . TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis. 2010; 31(11):1939-47. DOI: 10.1093/carcin/bgq180. View

12.

Salameh A, Fan X, Choi B, Zhang S, Zhang N, An Z . HER3 and LINC00052 interplay promotes tumor growth in breast cancer. Oncotarget. 2016; 8(4):6526-6539. PMC: 5351650. DOI: 10.18632/oncotarget.14313. View

13.

Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X . LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019; 10(1):3499. PMC: 6677832. DOI: 10.1038/s41467-019-11447-8. View

14.

Yu B, Chen X, Li J, Gu Q, Zhu Z, Li C . microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer. BMC Cancer. 2017; 17(1):109. PMC: 5294820. DOI: 10.1186/s12885-017-3096-9. View

15.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

16.

Yu G, Xiong D, Liu Z, Li Y, Chen K, Tang H . Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression. J Cell Biochem. 2019; 120(10):17258-17272. DOI: 10.1002/jcb.28988. View

17.

Lv M, Xu P, Wu Y, Huang L, Li W, Lv S . LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Oncotarget. 2016; 7(11):13047-59. PMC: 4914340. DOI: 10.18632/oncotarget.7509. View

18.

Zhang M, Song Y, Yu L . LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p. Am J Transl Res. 2019; 11(11):7186-7194. PMC: 6895514. View

19.

Liz J, Esteller M . lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2015; 1859(1):169-76. DOI: 10.1016/j.bbagrm.2015.06.015. View

20.

Tang H, Araki K, Li Z, Yamamura K . Characterization of Ayu17-449 gene expression and resultant kidney pathology in a knockout mouse model. Transgenic Res. 2008; 17(4):599-608. DOI: 10.1007/s11248-008-9170-y. View